Market News & Trends
Ipsen to Buy Syntaxin for $207 Million
Syntaxin recently announced it has been acquired by Ipsen, with which it has two major strategic alliances. Under the terms of the agreement, Ipsen will…
Surefire Medical’s Infusion System Found Safe & Effective for Liver Cancer
Case reports published in the Journal of Cardiovascular and Interventional Radiology found that by using the Surefire Infusion System, radioembolization could be successfully performed without…
Inovio’s Delivery Technology Powers Durable, Best-in-Class T-Cell Responses From HIV Vaccine
Inovio Pharmaceuticals, Inc. recently announced the peer-reviewed publication of results from two Phase I trials (HVTN 070 and HVTN 080) of its PENNVAX-B preventive HIV…
Purolite & Codexis Announce Development & Marketing Collaboration
Purolite Corporation and Codexis, Inc. recently announced a joint collaboration to develop and market immobilized enzymes for the pharmaceutical industry. Enzymes are immobilized through binding…
Patients & Physicians Express Desire to Switch to Transdermal Drug Delivery
The $82-billion US drug delivery market is showing no signs of saturation, with major patent expiries, generic competition, tightening FDA regulations, and emerging drug delivery…
Ocera Therapeutics Announces Merger Completion
Ocera Therapeutics, Inc. and Tranzyme, Inc. recently announced that following a special meeting of the shareholders of Tranzyme held on July 15, 2013, the Ocera…
Evotec Announces Collaboration on Cellular Target Profiling
Evotec AG recently announced that Evotec and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, have entered into a research collaboration with…
Aegis Awarded Patent for Absorption Enhancement for Peptide & Small Molecule Drugs
Aegis Therapeutics LLC recently announced it has been awarded US Patent No. 8,470,370 providing proprietary methods for sustained release, transdermal, or transmucosal absorption enhancement for…
Immunocore & GSK in Potential $500-Million Plus Deal
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, recently announced it has entered into a…
Catalent & Biota Expand Alliance
Catalent Pharma Solutions recently announced it has entered into a contract with Biota Pharmaceuticals, Inc. to develop and provide filling and packaging capabilities to supply…
VIVUS, Inc. Strikes $121-Million Drug Deal
VIVUS, Inc. recently announced it has entered into a license and commercialization agreement and a supply agreement with Menarini and its wholly owned subsidiary BERLIN-CHEMIE…
Vetter Offers a sWFI Solution With 5 Years Stability Data
Vetter recently announced it has has broadened its portfolio for lyophilized substances. The contract development and manufacturing organization (CDMO) is now offering its filling service…
Bioventus Buys Exclusive Rights to Pfizer Portfolio
Bioventus recently announced an agreement with Pfizer Inc. for an exclusive, worldwide license to Pfizer's bone morphogenetic protein (BMP) portfolio of development programs and associated…
Tengion Inc. Raises $33.6 Million to Advance Platform
Tengion, Inc. recently announced the closing of transactions totaling $33.6 million to fund its two lead clinical programs, the Neo-Kidney Augment and the Neo-Urinary Conduit.…
Glide Pharma Announces Design Optimization Agreement With Nypro Healthcare
Glide Pharma recently announced it has entered an agreement with global device manufacturer Nypro Healthcare to complete the design optimization of its solid dose injector…
West Expands Platform for Safe & Effective Injectable Drug Delivery
West Pharmaceutical Services, Inc. recently announced the expansion of the NovaGuard portfolio of needle safety products. The NovaGuard SA (Staked-needle Automatic) system, formerly called the…
Tapemark Wins Innovation Award
Tapemark recently announced that its Snapplicator packaging won the 2013 World of Wipes (WOW) Innovation Award from INDA, Association of the Nonwoven Fabrics Industry. The…
Avanir Pharmaceuticals & OptiNose Announce $110-Million Agreement
Avanir Pharmaceuticals, Inc. and OptiNose AS recently announced they have entered into an exclusive North American license agreement for the development and commercialization of OptiNose’s…
Bayer AG Strikes $520-Million Collaboration With Seattle Genetics, Inc.
Seattle Genetics, Inc. recently announced it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare. Under the latest relationship, Bayer will pay…
mPhase Technologies to Include R&D of Delivery Systems to its Smart NanoBattery Technology
mPhase Technologies, Inc. recently announced that is broadening its focus on its path-breaking battery technology to include research and development of drug delivery systems. In…
